# Lingering CAR T cells may be the cause of serious gut complication after myeloma therapy

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-lingering-car-cells-gut-complication.html) · 2026-11-19 · Medicine
Page: https://themorning.science/story/lingering-car-t-cells-may-be-the-cause-of-serious-gut-complication-after-myeloma-ea120e46835ffff4
Kind: research · Impact: medium

## In brief

- Patients with multiple myeloma who developed a serious gastrointestinal side effect after CAR T cell therapy had significantly more CAR T cells persisting in their bloodstream.
- The findings come from new research from The University of Texas MD Anderson Cancer Center.

## Why it matters

It suggests that prolonged persistence of CAR T cells may be linked to serious gut complications after myeloma treatment, which could inform how these patients are monitored.

## Coverage

- [Lingering CAR T cells may be the cause of serious gut complication after myeloma therapy](https://medicalxpress.com/news/2026-11-lingering-car-cells-gut-complication.html) — Medical Xpress - latest medical and health news stories, 2026-11-19

Tags: car t cells, multiple myeloma, immunotherapy, gastrointestinal side effects, cancer research

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
